Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Recurrence 1Rectal Neoplasms 1Neuroendocrine Tumors 1Melanoma 1Lymphoma, T-Cell, Peripheral 1Leukemia, Myeloid, Acute 1Leukemia, Erythroblastic, Acute 1Hodgkin Disease 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 75Etoposide 31Daunorubicin 27Filgrastim 24Mitoxantrone 23Idarubicin 23Busulfan 22Peripheral Blood Stem Cell Transplantation 20Cyclophosphamide 20fludarabine phosphate 19Gemtuzumab 14tipifarnib 11Antilymphocyte Serum 11Radiotherapy 10Methotrexate 10Cyclosporine 10Clofarabine 10sargramostim 9Gene Expression Profiling 9Flow Cytometry 9Azacitidine 9alvocidib 6aldesleukin 6Whole-Body Irradiation 6Vorinostat 6Topotecan 6Tacrolimus 6Bortezomib 6valspodar 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Erythroblastic, Acute × Salvage Therapy × Clear all
NCT04424147 2022-10-26

Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML

Nanfang Hospital, Southern Medical University

Phase 2 Completed
96 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡